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ABSTRACT 
Background: Studies have established the prognostic value of central systolic blood 
pressure and pulse pressure. The SphygmoCor XCEL device provides practical central 
blood pressure measurement for daily clinical use with its easy-to-use, operator-
independent procedure. However, this device has not been validated against invasive 
measurement.  
Method: Simultaneous oscillometric and high-fidelity invasive measurements of central 
systolic blood pressure and pulse pressure were compared for 36 patients who underwent 
coronary arteriography. Invasive measurement of brachial blood pressure was also 
performed. Oscillometrically measured brachial systolic and diastolic blood pressures 
were used for calibration.  
Results: The difference between the invasive and the oscillometric measurements were -
4.6±9.9 mmHg for central systolic blood pressure and -18.5±10.6 mmHg for central pulse 
pressure (mean ± standard deviation). We found strong correlation between the invasive 
and oscillometric measurements (central systolic blood pressure and central pulse 
pressure, respectively: r = 0.91 and 0.89; slope, 1.28 and 1.38; both p <0.001). Although 
the large slopes of the regression lines indicated a systemic bias toward lower values when 
measuring in high pressure ranges, the bias was mainly due to calibration error rather than 
device-specific error because errors of the central measurements correlated well with 
those of brachial measurements (systolic blood pressure and pulse pressure, respectively: 
r = 0.80 and 0.77; both p <0.001). 
Conclusion: The impaired accuracy of central blood pressure measurement was mainly 
due to calibration-derived, but not device-dependent, bias. Strong correlation between 
oscillometric and invasive measurements indicates that SphygmoCor XCEL warrants 
future investigations to determine the clinical validity of this device. 
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INTRODUCTION 
Central, rather than peripheral blood pressure (BP) can serve as a direct indicator of 
hemodynamic load to target organs including the heart and brain. Several reports support 
the rationale that central BP indicators, especially central systolic BP (SBP) and pulse 
pressure (PP), are superior to brachial BP indicators in terms of prediction of 
cardiovascular events.[1-3] Assessment of central BP may improve the identification and 
management patients with high risk for cardiovascular disease. 
The noninvasive approach to measuring central BP is widely used in research. The 
SphygmoCor CP system (AtCor Medical, Sydney, Australia), which derives central BP 
based on radial applanation tonometry, is the most commonly used device for noninvasive 
estimation of central BP.[4] However, the use of this device requires a trained operator, 
and is not feasible in daily clinical practice. Recently developed brachial cuff-based 
oscillometric devices can estimate central BP in an operator-independent manner. Some 
of these devices have already been validated against established invasive aortic BP 
techniques, with acceptable results,[5,6] and have proven clinical effective.[7-9] As 
simple, effective, and noninvasive alternatives to central BP measurement are now 
available, it is expected that the use of central BP will become widespread in daily clinical 
practice in the near future. 
The SphygmoCor XCEL (AtCor Medical), a novel brachial cuff-based device for 
estimating central BP, is designed for use in daily clinical practice and has already been 
applied in a recent international randomized controlled trial.[10] This device records 
brachial pressure waveforms using the brachial oscillometric cuff, and reconstructs the 
central aortic pressure waveforms based on a generalized transfer function (GTF) after 
calibration of cuff-derived brachial SBP and diastolic BP (DBP). There are two studies 
validating the SphygmoCor XCEL against the SphygmoCor CP, which is the most 
commonly used device.[11,12] However, both studies used the same cuff-derived brachial 
BP for calibration, and did not perform central BP assessment via an established invasive 
method for verification; thus, the presence of a similar bias of both SphygmoCor devices 
in relation to well-established invasive measurements cannot be ruled out. In particular, 
errors from calibration procedure (i.e., input errors; namely, errors in brachial BP based 
on the oscillometric method) have a crucial effect on the accuracy of central BP estimation 
(output errors).[13-16] Direct measurement of central and brachial BP by well-established 
invasive techniques is, therefore, necessary in order to assess the true magnitude of these 
errors. In this context, the purpose of the present study was to assess the validity of 
noninvasive central SBP and PP estimations derived from SphygmoCor XCEL 
measurements against reference values obtained from measurements with a high-fidelity 
invasive catheter. 
 
METHODS 
Patients 
Patients undergoing elective coronary angiography for assessment of coronary artery 
disease (CAD) at our institution were included. Exclusion criteria were unstable clinical 
conditions, arrhythmias during pulse recordings, moderate or severe valvular heart 
diseases, or exhibiting a difference of more than 5 mmHg between the left and right 
brachial SBP. The difference in brachial SBP between the two arms was assessed on the 
day before the study. Thirty-six eligible patients (13 female) were enrolled in accordance 
with the European Society of Hypertension International Protocol for the validation of 
blood pressure-measuring devices in adults.[17] This study was approved by our regional 
ethics committee, and all participants gave written informed consent. Patients were 
considered hypertensive if they exhibited brachial SBP ≥140 mmHg or brachial DBP ≥90 
mmHg, or made use of antihypertensive drugs. Patients were considered as having 
diabetes mellitus if they exhibited fasting blood glucose levels of ≥126 mg/dL, HbA1c ≥ 
6.5 %, or made use of hypoglycemic agents or insulin. Patients were considered as having 
CAD if they exhibited a stenosis of >50% in a major epicardial coronary artery, or if they 
underwent prior percutaneous coronary intervention. 
 Measurement of central and brachial BP 
All measurements were performed in the supine position on the catheterization table. 
Usual medications were not withheld for this study, but no vasoactive drug was 
administered during the measurement.  
For the invasive measurement, a homeostatic sheath (Radifocus, Terumo Medical, Tokyo, 
Japan) was placed via radial approach. The arm through which to cannulate the artery was 
chosen based on the Allen’s test (right arm, 61.1%; left arm, 38.9%). A high-fidelity 
pressure wire (diameter 0.014”, Certus® or Aeris®, St Jude Medical) was set at 0 mmHg, 
calibrated, and introduced through the guiding catheter into the proximal aortic root under 
radiographic guidance. Central aortic pressure waveform was digitally recorded at 100 
Hz, for 30 to 60 seconds. The pressure guide wire was subsequently pulled to the 
brachium and the brachial pressure waveform was recorded in a similar manner. 
Invasively recorded pressure waveforms were analyzed for obtaining the BP parameters 
during the 30- to 60-second recording period. Finally, the values of the invasively-
measured SBP, DBP and PP were calculated from the waveform.  
The central pressure waveform was also recorded noninvasively with the SphygmoCor 
XCEL, simultaneously to the invasive measurement. The SphygmoCor XCEL consists of 
a brachial cuff-based central BP estimating device validated against a tonometric device, 
the SphygmoCor CP. The brachial pressure waveforms were calibrated with cuff-
measured brachial SBP and DBP, and then transformed to central aortic waveforms by 
the device’s software using a GTF. A properly sized cuff, according to the manufacturer's 
instruction, was fitted on the contralateral brachium (the arm not used for the sheath 
insertion), and three repeated measurements were performed by trained investigators. 
Finally, the three recordings were averaged in order to calculate the noninvasively-
measured SBP, DBP and PP values.  
 
Statistical analysis 
All data were analyzed using STATA 14.1 software. All continuous values were expressed 
as mean ± standard deviation (SD), and categorical variables were reported as percentages. 
Agreement between the measurements made with the SphygmoCor XCEL and with the 
invasive catheter was assessed using the paired samples t-test and the Bland-Altman 
analysis. Pearson's linear correlation test was used to analyze the correlations between BP 
values of the paired invasive and noninvasive measurements, and the correlations 
between the errors of brachial SBP/PP (input error) and central SBP/PP (output error). All 
P-values were two-tailed. P-values <0.05 were considered statistically significant.  
 
RESULTS 
Patient Characteristics 
The 36 enrolled patients included 13 female patients (36.1%), 28 hypertensive patients 
(77.8%), 9 diabetic patients (25.0%), and 29 patients with CAD (80.6%, Table 1). Mean 
age of the patients was 69.1±13.5 years (range, 23-88 years). Twenty-eight patients 
(77.8%) were prescribed vasoactive drugs including renin-angiotensin system inhibitors, 
beta blockers, calcium-channel blockers, and nitrates.  
 
Comparison between SphygmoCor XCEL derived and invasive catheter derived BP 
The SphygmoCor XCEL underestimated central SBP by 4.6 mmHg, and the SD of the 
difference was large (9.9 mmHg) (Table 2). The average of brachial SBP values 
noninvasively-measured was comparable to that of the invasive measurement, but the SD 
of the difference was also large (8.0 mmHg). The SBP scatter plots of noninvasive versus 
invasive measurements are shown in Figure 1A. Although the slopes and intercepts were 
distant from 1.0 and zero, respectively, for both central and brachial SBPs (central SBP: 
y = 1.15·x - 28.8; brachial SBP: y = 1.15·x - 20.0), the correlation coefficients (r) were 
very high (central SBP: r = 0.93; brachial SBP: r = 0.91). Bland-Altman plots of these 
data showed significant upward slopes for both central and brachial SBPs (Figure 1B). 
  With regard to DBP, the SphygmoCor XCEL considerably overestimated central and 
brachial values, but the SDs were relatively small (central DBP: 13.4±6.4 mmHg; brachial 
DBP: 11.7±6.9 mmHg) (Table 2). The DBP scatter plots of noninvasive versus invasive 
measurements showed that the slopes were smaller than 1.0, but the intercepts were near 
zero for both central and brachial DBPs (Figure S1A). The r values were 0.83 for central 
DBP and 0.80 for brachial DBP. Bland-Altman plots did not show a clear trend as they 
did for SBP (Figure S1B). 
  The underestimation of SBP and overestimation of DBP account for the additive 
underestimation of PP for both central and brachial artery (Table 2). The PP scatter plots 
of noninvasive versus invasive measurements showed that the slopes were larger than 1.0, 
but the intercepts were near zero for both central and brachial PPs (Figure 2A). The r 
values were 0.89 for central PP and 0.90 for brachial PP, being similarly high to those of 
SBP. The corresponding Bland-Altman plots showed similar upward slopes to those 
found in SBP (Figure 2B). 
 
Relationships between input error and output error 
Figure 3 demonstrates the correlation between output error and input error. Output errors 
in SBP and PP (differences between invasively- and noninvasively-measured central 
SBPs or PPs) highly correlated with their corresponding input errors (differences between 
invasively- and noninvasively-measured brachial SBPs or PPs), suggesting that the 
accuracy for central SBP and PP estimation was mainly impaired by the calibration error 
derived from the oscillometric method.  
 
  
DISCUSSION 
To the best of our knowledge, this is the first study validating the SphygmoCor XCEL 
against well-established invasive techniques. We found that the cuff measurement error 
in brachial SBP and PP (i.e., input error) impaired the accuracy of the estimated central 
SBP and PP (i.e., output error); these results suggest that, in the SphygmoCor XCEL, 
input errors are transferred to output errors, which is a common problem to the tonometric 
device: the SphygmoCor CP. We noted strong significant correlations between 
measurements obtained via invasive catheter and the values estimated via the 
SphygmoCor XCEL,which warrants future investigations to determine the clinical 
validity of this device. 
 Two early studies reported that the SphygmoCor XCEL provided comparable estimation 
of central SBP to the SphygmoCor CP.[11,12] Although this present study also showed 
that the mean bias of the noninvasively-measured central SBP was within the acceptable 
limit (<5 mmHg)[18] in comparison with invasive measurement, we found a systemic 
bias in estimated central SBP as indicated by the large slope of the regression line. A 
similar bias observed in estimated brachial SBP and the strong correlation between the 
output errors and the input errors (r = 0.80, P<0.01) leaded us to conclude that this bias 
was mainly due to the input errors (i.e.calibration errors). Although the accuracy of central 
BP estimation by GTF largely depends on the accuracy of calibration,[13-16] noninvasive 
brachial BP estimation is coexistent with a consistent error.[15,19-21] This finding and 
our results indicate the systemic bias of estimated central SBP with this device is a 
common rather than device-specific issue among noninvasive devices including 
SphygmoCor CP and XCEL. 
The considerable underestimation of central PP noted in the present study 
(approximately 19 mmHg) was within the limits reported in literature; specifically, in 
almost all devices that rely on the oscillometric method, input errors consisting of 
underestimation of brachial SBP and overestimation of brachial DBP lead to the 
underestimation of central PP (output errors).[5,13,15] Moreover, as expected, the error 
in central PP estimation was largely determined by the error in cuff-derived brachial PP, 
as was the case with the estimation of central SBP.  
  While the accuracy of the SphygmoCor XCEL in estimating central SBP and PP was 
impaired by calibration errors, the usefulness of the device should be judged also based 
on its diagnostic and predictive ability. This device was shown to provide comparable 
estimation of central BP with the tonometric SphygmoCor device,[11,12] the clinical 
validity of which has been well established in several studies.[1,22,23] Furthermore, we 
found that estimated central SBP and PP strongly correlated with invasively measured 
values, which warrants future studies investigating the diagnostic and predictive ability 
of the SphygmoCor XCEL.  
  Although the SDs of the mean bias for the noninvasive estimates of central SBP and 
PP were above the acceptable limit (<8 mmHg), the Bland-Altman plots of SBP and PP 
suggested that the large SDs were considerably due to the upward trend of the regression 
lines, which resulted in increased SD as the range of BP widened. Since the scattering of 
values along the regression line was narrow, we speculated that the large SDs were due 
to the systemic bias of the brachial BP rather than the lack of precision of the SphygmoCor 
XCEL. 
  Our findings must be considered within the context of the strengths and limitations of 
our study. A major strength of the present study was that the validation of the 
SphygmoCor XCEL as a clinically valuable device for estimating central BP was 
performed against a well-established invasive technique that relies on a high-fidelity BP 
measuring system. In addition, the simultaneous measurement of brachial BP via invasive 
(direct) methods allowed us to assess the magnitude and source of the error in central BP 
estimation. On the other hand, our study included patients who underwent coronary 
angiography, resulting in a high prevalence of high-risk patients. This represents a 
limitation of the study, because such patients often take vasoactives that might affect the 
accuracy and precision of noninvasive central BP estimation. 
 
Perspectives 
As brachial cuff-based oscillometric devices can be used in an operator-independent 
manner, it is expected that their application for estimation of central BP will become 
routine in clinical practice. We present the validation of such a device, the SphygmoCor 
XCEL, against a well-established invasive technique for high-fidelity measurement of 
central BP. We found that the estimated values strongly correlate with the values obtained 
by the invasive approach, and concluded that the SphygmoCor XCEL is likely to provide 
reliable estimates of the central SBP and PP for use in daily clinical practice. However, 
as limited clinical data are available regarding this device, further study is warranted to 
assess the diagnostic and predictive ability of the central SBP and PP estimated using the 
SphygmoCor XCEL.  
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Figure legends 
Figure 1. Scatterplots (A) and Bland-Altman plots (B) of SBP measured using an 
invasive catheter vs. using the SphygmoCor XCEL device.  
A. The dotted lines indicate the identity line. The regression lines were drawn as solid 
lines.  
B. Horizontal lines at the mean value (solid lines) and plus and minus two standard 
deviations (dotted lines) were drawn. The regression lines were drawn as solid lines. 
SBP, systolic blood pressure; c, central; b, brachial; inv, measured with an invasive 
catheter; xcel, measured with the SphygmoCor XCEL; SD, standard deviation. 
 
Figure 2. Scatterplots (A) and Bland-Altman plots (B) of PP measured using an 
invasive catheter derived vs. using the SphygmoCor XCEL device. 
A. The dotted lines indicate the identity line. The regression lines were drawn as solid 
lines.  
B. Horizontal lines at the mean value (solid lines) and plus and minus two standard 
deviations (dotted lines) were drawn. The regression lines were drawn as solid lines. 
PP, pulse pressure; c, central; b, brachial; inv, measured with invasive catheter; xcel, 
measured with the SphygmoCor XCEL; SD, standard deviation. 
 Figure 3. Scatterplots of output vs. input errors in the estimation of central SBP and PP. 
The dotted lines indicated the identity line. The regression lines were drawn as solid 
lines. 
SBP, systolic blood pressure; PP, pulse pressure; c, central; b, brachial; inv, measured 
with invasive catheter; xcel, measured with the SphygmoCor XCEL. 
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